United States · FDA National Drug Code directory
hydrochlorothiazide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62332-070_b3a6e9ad-418d-420f-bb45-9c1bc8df2337
- Product NDC
- 62332-070
- Form
- CAPSULE
- Composition / generic term
- Hydrochlorothiazide
- Labeler
- Alembic Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170302
- Source listing expiry
- 20261231
Source-listed ingredients
- HYDROCHLOROTHIAZIDE — 12.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 BLISTER PACK in 1 CARTON (62332-070-10) / 10 CAPSULE in 1 BLISTER PACK · 62332-070-10
- 30 CAPSULE in 1 BOTTLE (62332-070-30) · 62332-070-30
- 100 CAPSULE in 1 BOTTLE (62332-070-31) · 62332-070-31
- 500 CAPSULE in 1 BOTTLE (62332-070-71) · 62332-070-71
- 1000 CAPSULE in 1 BOTTLE (62332-070-91) · 62332-070-91
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →